ATE56147T1 - T-pa enthaltende medizinische zubereitung und deren verwendung. - Google Patents

T-pa enthaltende medizinische zubereitung und deren verwendung.

Info

Publication number
ATE56147T1
ATE56147T1 AT87104825T AT87104825T ATE56147T1 AT E56147 T1 ATE56147 T1 AT E56147T1 AT 87104825 T AT87104825 T AT 87104825T AT 87104825 T AT87104825 T AT 87104825T AT E56147 T1 ATE56147 T1 AT E56147T1
Authority
AT
Austria
Prior art keywords
preparation containing
medicinal preparation
meglumine
tpa
medicament
Prior art date
Application number
AT87104825T
Other languages
English (en)
Inventor
Fumio Kakimoto
Naoki Asakawa
Yasuo Ishibashi
Yasuo Miyake
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of ATE56147T1 publication Critical patent/ATE56147T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT87104825T 1986-04-02 1987-04-01 T-pa enthaltende medizinische zubereitung und deren verwendung. ATE56147T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP61074370A JPH0678241B2 (ja) 1986-04-02 1986-04-02 ｔＰＡ医薬組成物
EP87104825A EP0242653B1 (de) 1986-04-02 1987-04-01 T-PA enthaltende medizinische Zubereitung und deren Verwendung

Publications (1)

Publication Number Publication Date
ATE56147T1 true ATE56147T1 (de) 1990-09-15

Family

ID=13545204

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87104825T ATE56147T1 (de) 1986-04-02 1987-04-01 T-pa enthaltende medizinische zubereitung und deren verwendung.

Country Status (8)

Country Link
US (1) US4985245A (de)
EP (1) EP0242653B1 (de)
JP (1) JPH0678241B2 (de)
AT (1) ATE56147T1 (de)
CA (1) CA1289472C (de)
DE (1) DE3764697D1 (de)
ES (1) ES2031846T3 (de)
GR (1) GR3000751T3 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2520975B2 (ja) * 1989-09-21 1996-07-31 三井東圧化学株式会社 組織プラスミノ―ゲンアクチベ―タ―若しくはその誘導体を含有する血栓溶解剤
DE3942141A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh K2p pro-stabilisierung
DE3942143A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh T-pa pro stabilisierung
DE3942142A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh Stabilisierung von glykosyliertem t-pa
GB0007239D0 (en) * 2000-03-24 2000-05-17 Nycomed Imaging As Use
JP5468221B2 (ja) * 2008-08-04 2014-04-09 株式会社 メドレックス 難溶性薬物の静注用分散製剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5137343B2 (de) * 1972-12-07 1976-10-15
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
DE3584902D1 (de) * 1984-02-29 1992-01-30 Asahi Chemical Ind Waessrige loesung eines darin in erhoehter konzentration aufgeloesten gewebe-plasminogen-aktivators und herstellungsverfahren.

Also Published As

Publication number Publication date
CA1289472C (en) 1991-09-24
EP0242653A1 (de) 1987-10-28
GR3000751T3 (en) 1991-10-10
JPS62234030A (ja) 1987-10-14
JPH0678241B2 (ja) 1994-10-05
EP0242653B1 (de) 1990-09-05
ES2031846T3 (es) 1996-07-16
DE3764697D1 (de) 1990-10-11
US4985245A (en) 1991-01-15

Similar Documents

Publication Publication Date Title
BG60253B1 (bg) Човешки тъканен плазминогенен активатор
ATE70191T1 (de) Knochenzement zur kontrollierten abgabe von wirkstoffen.
NO951592L (no) Fremgangsmåte for fremstilling av et transdermalt terapeutisk system
EP0151989A3 (en) Means for the treatment of cardiac diseases
ES2000743A6 (es) Estuche y procedimiento para preparar una unidad de dosificacion de activador de plasminogeno de tejidos humanos.
HU910979D0 (en) Process for the prodiction of medical preparations with n-neuropeptide-antagonistic effect, containing guanidine derivatives
ATE56147T1 (de) T-pa enthaltende medizinische zubereitung und deren verwendung.
SE8400723L (sv) Farmaceutisk komposition
DE69108748D1 (de) Antithrombin-Lösung und ihre Verwendung.
IE890580L (en) Therapeutic agent for the prevention of intraventricular hemorrhage in premature infants
IL87566A0 (en) Medical composition for the treatment of diabetes comprising a benzamide derivative
FI913625A0 (fi) Behandling av nedsatt funktion av leukocyter med gm-csf.
HUT47221A (en) Process for production of medical compositions containing as active substance human xiii factor
AU584548B2 (en) Sterilization of adsorbent and column having improved storability including sterilized adsorbent for use in extracorporeal circulation treatment
ES2094757T3 (es) Un factor megacariocitopoyetico.
ES2077698T3 (es) Agente terapeutico para la gangrena diabetica.
ATE75938T1 (de) Enantiomere des propafenons enthaltende therapeutische mittel.
ATE40795T1 (de) Verwendung eines zerebral und peripher wirkenden antihypoxidotikums.
ATE84418T1 (de) 2,6-diamino-3-phenyl-azo-pyridin enthaltendes tier- und humanarzneimittel mit antiviraler und antitumoraler aktivitaet.
FI883177A0 (fi) Anvaendning av ett medium med hoeg affinitet foer tumoerer.
ATE136776T1 (de) Verwendung von heptastigmin zur behandlung der zerebralen ictus
ATE72397T1 (de) Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit.
NO881798D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee